Skip to content
Cystotech logo — Providing AI based support for treatment decision in bladder...

Cystotech

Providing AI based support for treatment decision in bladder cancer

Founded 2021 Denmark Denmark 15 employees Medical Devices

General Information

Company Name Cystotech
Founded Year 2021
Location Denmark Denmark
Employees 15
Industries Medical Devices
Social

BounceWatch is an independent company data service, not affiliated with Cystotech. To contact Cystotech, visit cystotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cystotech compare?

A PDF of Cystotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cystotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cystotech

Cystotech is a Denmark-based startup founded in 2021 with the slogan "Providing AI based support for treatment decision in bladder cancer." The company is focused on utilizing AI to aid in treatment decision-making for bladder cancer patients. Cystotech has positioned itself at the intersection of healthcare and technology, aiming to revolutionize the way bladder cancer is diagnosed and treated. With a unique approach to leveraging artificial intelligence in the medical field, the company has the potential to make a significant impact on patient care and outcomes. As of now, there is no public information available about the last investment or the investors involved with Cystotech. This suggests that the company may still be in the early stages of seeking external funding or is self-funded. The potential for Cystotech to disrupt the traditional methods of treating bladder cancer with their innovative AI-based solution makes them an intriguing prospect for investors looking to support groundbreaking advancements in healthcare technology.

Business keywords: AI-based support, bladder cancer, treatment decisions, oncology, medical AI, cancer treatment, clinical decision support, health tech, oncology AI, precision medicine

No funding data available for Cystotech yet.

Cystotech Alternatives & Competitors

View All Alternatives
Cystotech vs

Developing innovative vaccines for prostate cancer patients and a test to determine their effectiven...

Venture round
Biotechnology, Health Care
Cystotech vs
MYPL
MYPL France

A game changing innovative approach to data structuration, patient care and clinical decision suppor...

8 employees
Health Care, Information Technology
Cystotech vs
ViewRay, Inc.
ViewRay, Inc. United States

Conquer cancer by re-envisioning radiation therapy.

Post-IPO Debt
76 employees
Biotechnology, Health Care

FAQ About Cystotech

Providing AI based support for treatment decision in bladder cancer
Cystotech was founded in 2021.
Cystotech is headquartered in Denmark.
Cystotech operates in Medical Devices. Its work centres on AI-based support, bladder cancer, treatment decisions and oncology.
Cystotech has approximately 15 employees.
Top alternatives and competitors to Cystotech include Madison Vaccines, MYPL, ViewRay, Inc., Nucleix Ltd., NU-RISE LDA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cystotech and Madison Vaccines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cystotech, https://bouncewatch.com/company/cystotech, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout